Location: LUXEMBOURG, N4
CIK: 0001053906 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 14, 2026
Total Value ($000): $1,010,582 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 154,734,327 (+13.6%) | $241,386 (+54.1%) | 23.9% | $3.68 | -63.4% | COM NEW | 528872302 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CAVA | Cava Group Inc | 9,507,990 | $769,196 | 76.1% | $41.17 | +64.0% | COM | 148929102 |